Applied Therapeutics Performance Analysis: GAAP EPS Exceeds Expectations Amid Revenue Miss

Wednesday, 6 March 2024, 12:31

Applied Therapeutics recently announced its financial results, with a GAAP EPS of -$1.42 surpassing expectations by $0.02. However, the revenue of $10 million fell short by $0.67 million. This mixed performance reflects the company's operational efficiency challenges and growth potential in the market.
LivaRava Finance Meta Image
Applied Therapeutics Performance Analysis: GAAP EPS Exceeds Expectations Amid Revenue Miss

Applied Therapeutics Financial Report Overview

Applied Therapeutics recently disclosed its latest financial results, generating a mix of reactions from investors and analysts.

Key Highlights:

  • GAAP EPS: -$1.42 (beat by $0.02)
  • Revenue: $10 million (misses by $0.67 million)

The company's strong EPS performance was overshadowed by revenue falling short, highlighting both areas of strength and concern.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe